Disseminated cutaneous lymphoid hyperplasia of 12 years' duration triggered by vaccination

Dermatology

Volumn 220, Issue 2, 2010, Pages 176-179

  Pham Ledard, Anne ^a   Vergier, Beatrice ^a   Doutre, Marie Sylvie ^a   Beylot Barry, Marie ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Cutaneous lymphoid hyperplasia; Pseudolymphoma; Thalidomide; Vaccination

Indexed keywords

ALUMINUM HYDROXIDE; CYCLINE; HEPATITIS B VACCINE; HYDROXYCHLOROQUINE; THALIDOMIDE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE DURATION; DRUG EFFICACY; FEMALE; HUMAN; INFLAMMATION; INJECTION SITE; LYMPHOID HYPERPLASIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ANTIGENS, CD3; B-LYMPHOCYTES; CYCLINS; DNA-BINDING PROTEINS; FEMALE; HEPATITIS B VACCINES; HUMANS; HYDROXYCHLOROQUINE; NEPRILYSIN; PSEUDOLYMPHOMA; SKIN NEOPLASMS; T-LYMPHOCYTES; THALIDOMIDE; VACCINATION;

EID: 77949264150     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000269845     Document Type: Article

References (11)

1. Choffray A, Pinquier L, Bachelez H: Exacerbation of lupus panniculitis following anti-hepatitis-B vaccination. Dermatology 2007; 215:152-154.
2. Ploysangam T, Breneman DL, Mutasim DF: Cutaneous pseudolymphomas. J Am Acad Dermatol 1998; 38:877-895, quiz 896-897.
3. Atalar H, Sarifakioglu E, Dener C, Yanik B, Koktener A, Bayrak R: Cutaneous lymphoid hyperplasia and reactive lymphadenopathy induced by hepatitis B vaccination. Eur J Dermatol 2008; 18:188-189.
4. Cerroni L, Borroni RG, Massone C, Chott A, Kerl H: Cutaneous B-cell pseudolymphoma at the site of vaccination. Am J Dermatopa-thol 2007; 29:538-542.
5. Chong H, Brady K, Metze D, Calonje E: Persistent nodules at injection sites (aluminium granuloma) - clinicopathological study of 14 cases with a diverse range of histological reaction patterns. Histopathology 2006;48:182-188.
6. Croce S, Lhermitte B, Tomasetto C, Guillard O, Bellocq JP, Chenard MP: Late-onset vaccination-induced subcutaneous pseudolym-phoma. Ann Pathol 2008; 28:146-149.
7. Lanzafame S, Micali G: Cutaneous lymphoid hyperplasia (pseudolymphoma) secondary to vaccination. Pathologica 1993;85:555-561.
8. Maubec E, Pinquier L, Viguier M, Caux F, Amsler E, Aractingi S, Chafi H, Janin A, Cayuela JM, Dubertret L, Authier FJ, Bach-elez H: Vaccination-induced cutaneous pseudolymphoma. J Am Acad Dermatol 2005; 52:623-629.
9. May SA, Netto G, Domiati-Saad R, Kasper C: Cutaneous lymphoid hyperplasia and marginal zone B-cell lymphoma following vaccination. J Am Acad Dermatol 2005;53:512-516.
10. Stavrianeas NG, Katoulis AC, Kanelleas A, Hatziolou E, Georgala S: Papulonodular li-chenoid and pseudolymphomatous reaction at the injection site of hepatitis B virus vaccination. Dermatology 2002; 205:166-168.
11. Gerlini G, Mori M, Massi D, Pimpinelli N: Specific immune therapy-related cutaneous B-cell pseudolymphoma with following dissemination. J Eur Acad Dermatol Venereol 2003; 17:208-212.